Viewing Study NCT06658834


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-27 @ 11:47 PM
Study NCT ID: NCT06658834
Status: RECRUITING
Last Update Posted: 2024-10-26
First Post: 2024-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module